|
CIAO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.32240001966034E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.10399994596366E-09 |
| Normal-vs-Stage2 |
4.337600E-02 |
| Normal-vs-Stage3 |
2.457900E-02 |
| Normal-vs-Stage4 |
3.207600E-01 |
| Stage1-vs-Stage2 |
4.080400E-01 |
| Stage1-vs-Stage3 |
1.677200E-01 |
| Stage1-vs-Stage4 |
1.678590E-01 |
| Stage2-vs-Stage3 |
7.842400E-01 |
| Stage2-vs-Stage4 |
5.743600E-01 |
| Stage3-vs-Stage4 |
6.779600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.19740001142321E-09 |
| Normal-vs-AfricanAmerican |
4.386000E-04 |
| Normal-vs-Asian |
3.181400E-01 |
| Caucasian-vs-AfricanAmerican |
4.387000E-01 |
| Caucasian-vs-Asian |
5.087400E-01 |
| AfricanAmerican-vs-Asian |
7.375800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.55469986779156E-10 |
| Normal-vs-Female |
5.364300E-03 |
| Male-vs-Female |
5.855400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.55023999999226E-05 |
| Normal-vs-Extreme_Weight |
2.23350005157386E-09 |
| Normal-vs-Obese |
1.185460E-04 |
| Normal-vs-Extreme_Obese |
1.160440E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.956600E-01 |
| Normal_Weight-vs-Obese |
4.255800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.469200E-01 |
| Extreme_Weight-vs-Obese |
1.016820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.747200E-01 |
| Obese-vs-Extreme_Obese |
8.061800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.009200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.231210E-04 |
| Normal-vs-Age(61-80Yrs) |
1.92460047898635E-10 |
| Normal-vs-Age(81-100Yrs) |
1.243330E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.769000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.825880E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.264700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.438700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.592400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.955000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.93689999991886E-08 |
| Normal-VS-Type2 PRCC |
3.42210000003895E-06 |
| Normal-VS-KIRP CIMP |
1.837750E-01 |
| Normal-VS-Unclassified PRCC |
2.457700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.372200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.331600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.569600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.934400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.911600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.363800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.96299999999372E-06 |
| Normal-vs-N1 |
2.695800E-01 |
| Normal-vs-N2 |
2.838500E-02 |
| N0-vs-N1 |
6.163900E-02 |
| N0-vs-N2 |
7.555000E-01 |
| N1-vs-N2 |
6.012200E-01 |
|
|
